PubMed

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

Haubrich RH, Riddler SA, DiRienzo AG, Komarow L, Powderly WG, Klingman K, Garren KW, Butcher DL, Rooney JF, Haas DW, Mellors JW, Havlir DV; AIDS Clinical Trials Group (ACTG) A5142 Study Team.

AIDS. 2009 Jun 1;23(9):1109-18.PMID: 19417580 [PubMed - indexed for MEDLINE]Related articles

Complications of HIV disease and antiretroviral therapy.

Currier JS, Havlir DV.

Top HIV Med. 2009 Apr-May;17(2):57-67. Review.PMID: 19401608 [PubMed - indexed for MEDLINE]Related articlesFree article

Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis.

Davis JL, Huang L, Kovacs JA, Masur H, Murray P, Havlir DV, Worodria WO, Charlebois ED, Srikantiah P, Cattamanchi A, Huber C, Shea YR, Chow Y, Fischer SH.

Clin Infect Dis. 2009 Mar 15;48(6):725-32.PMID: 19207077 [PubMed - indexed for MEDLINE]Related articles

Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.

Srikantiah P, Wong JK, Liegler T, Walusimbi M, Mayanja-Kizza H, Kayanja HK, Mugerwa RD, Charlebois ED, Boom WH, Whalen CC, Havlir DV.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):458-60. No abstract available. PMID: 19011423 [PubMed - indexed for MEDLINE]Related articles

HIV integrase inhibitors--out of the pipeline and into the clinic.

Havlir DV.

N Engl J Med. 2008 Jul 24;359(4):416-8. No abstract available. PMID: 18650518 [PubMed - indexed for MEDLINE]Related articles

Opportunities and challenges for HIV care in overlapping HIV and TB epidemics.

Havlir DV, Getahun H, Sanne I, Nunn P.

JAMA. 2008 Jul 23;300(4):423-30.PMID: 18647985 [PubMed - indexed for MEDLINE]Related articlesFree article

Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.

Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV.

Clin Infect Dis. 2008 Aug 1;47(3):421-4.PMID: 18558886 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV RNA suppression among HIV-infected Ugandan children with measles.

Ruel TD, Achan J, Gasasira AF, Charlebois ED, Mehbratu T, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir DV.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):225-7. No abstract available. PMID: 18520684 [PubMed - indexed for MEDLINE]Related articles

Complications of HIV disease and therapy.

Currier JS, Havlir DV.

Top HIV Med. 2008 Apr-May;16(1):23-30.PMID: 18441380 [PubMed - in process]Related articlesFree article

Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials.

Blanc FX, Havlir DV, Onyebujoh PC, Thim S, Goldfeld AE, Delfraissy JF.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S46-51. Review.PMID: 17624825 [PubMed - indexed for MEDLINE]Related articles

Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.

Srikantiah P, Walusimbi MN, Kayanja HK, Mayanja-Kizza H, Mugerwa RD, Lin R, Charlebois ED, Boom WH, Whalen CC, Havlir DV.

AIDS. 2007 Sep 12;21(14):1972-4.PMID: 17721107 [PubMed - indexed for MEDLINE]Related articles

High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response.

Podzamczer D, King MS, Klein CE, Flexner C, Katlama C, Havlir DV, Letendre SL, Eron JJ, Brun SC, Bernstein B.

HIV Clin Trials. 2007 Jul-Aug;8(4):193-204.PMID: 17720659 [PubMed - indexed for MEDLINE]Related articlesFree article

Complications of HIV disease and therapy.

Currier JS, Havlir DV.

Top HIV Med. 2007 Apr-May;15(2):40-7.PMID: 17485786 [PubMed - indexed for MEDLINE]Related articlesFree article

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.

Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM; AIDS Clinical Trials Group 5170 Study Team.

J Infect Dis. 2007 May 15;195(10):1426-36. Epub 2007 Apr 6.PMID: 17436222 [PubMed - indexed for MEDLINE]Related articles

Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention.

Srikantiah P, Lin R, Walusimbi M, Okwera A, Luzze H, Whalen CC, Boom WH, Havlir DV, Charlebois ED.

Int J Tuberc Lung Dis. 2007 Feb;11(2):168-74.PMID: 17263287 [PubMed - indexed for MEDLINE]Related articles

Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals.

Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV.

Am J Respir Crit Care Med. 2007 Apr 1;175(7):737-42. Epub 2007 Jan 11.PMID: 17218620 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.

Benson CA, Vaida F, Havlir DV, Downey GF, Lederman MM, Gulick RM, Glesby MJ, Wantman M, Bixby CJ, Rinehart AR, Snyder S, Wang R, Patel S, Mellors JW; ACTG A5086 Study Team.

J Infect Dis. 2006 Nov 1;194(9):1309-18. Epub 2006 Sep 22.PMID: 17041858 [PubMed - indexed for MEDLINE]Related articles

Intensive care of patients with HIV infection.

Huang L, Quartin A, Jones D, Havlir DV.

N Engl J Med. 2006 Jul 13;355(2):173-81. Review. No abstract available. PMID: 16837681 [PubMed - indexed for MEDLINE]Related articles

Complications of HIV disease and antiretroviral therapy.

Havlir DV, Currier JS.

Top HIV Med. 2006 Mar-Apr;14(1):27-35.PMID: 16641525 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral therapy and TB.

Swaminathan S, Luetkemeyer A, Srikantiah P, Lin R, Charlebois E, Havlir DV.

Trop Doct. 2006 Apr;36(2):73-9. Review.PMID: 16611437 [PubMed - indexed for MEDLINE]Related articles

Patents versus patients? Antiretroviral therapy in India.

Havlir DV, Hammer SM.

N Engl J Med. 2005 Aug 25;353(8):749-51. No abstract available. PMID: 16120852 [PubMed - indexed for MEDLINE]Related articles

Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors.

Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ.

Antimicrob Agents Chemother. 2005 Jul;49(7):2983-5.PMID: 15980379 [PubMed - indexed for MEDLINE]Related articlesFree article

Complications of HIV disease and antiretroviral therapy.

Currier JS, Havlir DV.

Top HIV Med. 2005 Mar-Apr;13(1):16-23.PMID: 15849369 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK.

J Infect Dis. 2005 May 1;191(9):1410-8. Epub 2005 Mar 29.PMID: 15809898 [PubMed - indexed for MEDLINE]Related articles

Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.

Havlir DV, Koelsch KK, Strain MC, Margot N, Lu B, Ignacio CC, Miller MD, Wong JK; Gilead 903 Study Team.

J Infect Dis. 2005 Apr 1;191(7):1164-8. Epub 2005 Feb 28.PMID: 15747253 [PubMed - indexed for MEDLINE]Related articles

Rapid increase in tuberculosis incidence soon after infection with HIV--a new twist in the twin epidemics.

Srikantiah P, Charlebois E, Havlir DV.

J Infect Dis. 2005 Jan 15;191(2):147-9. Epub 2004 Dec 13. No abstract available. PMID: 15609222 [PubMed - indexed for MEDLINE]Related articles

The case for earlier treatment of HIV infection.

Holmberg SD, Palella FJ Jr, Lichtenstein KA, Havlir DV.

Clin Infect Dis. 2004 Dec 1;39(11):1699-704. Epub 2004 Nov 9. Review. Erratum in: Clin Infect Dis. 2004 Dec 15;39(12):1869. PMID: 15578373 [PubMed - indexed for MEDLINE]Related articles

Atazanavir: new option for treatment of HIV infection.

Havlir DV, O'Marro SD.

Clin Infect Dis. 2004 Jun 1;38(11):1599-604. Epub 2004 May 13. Review.PMID: 15156449 [PubMed - indexed for MEDLINE]Related articles

Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.

Currier JS, Havlir DV.

Top HIV Med. 2004 Mar-Apr;12(1):31-45.PMID: 15111728 [PubMed - indexed for MEDLINE]Related articlesFree article

Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years.

Havlir DV, Strain MC, Clerici M, Ignacio C, Trabattoni D, Ferrante P, Wong JK.

J Virol. 2003 Oct;77(20):11212-9.PMID: 14512569 [PubMed - indexed for MEDLINE]Related articlesFree article

Strategic approaches to antiretroviral treatment.

Havlir DV.

Top HIV Med. 2003 Jul-Aug;11(4):145-9.PMID: 12876333 [PubMed - indexed for MEDLINE]Related articlesFree article

Complications of HIV infection and antiretroviral therapy.

Havlir DV, Currier JS.

Top HIV Med. 2003 May-Jun;11(3):86-91. Review. No abstract available. PMID: 12837967 [PubMed - indexed for MEDLINE]Related articlesFree article

Responding to organ failure in HIV-infected patients.

Roland ME, Havlir DV.

N Engl J Med. 2003 Jun 5;348(23):2279-81. No abstract available. PMID: 12788990 [PubMed - indexed for MEDLINE]Related articles

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence.

Strain MC, Günthard HF, Havlir DV, Ignacio CC, Smith DM, Leigh-Brown AJ, Macaranas TR, Lam RY, Daly OA, Fischer M, Opravil M, Levine H, Bacheler L, Spina CA, Richman DD, Wong JK.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4819-24. Epub 2003 Apr 8.PMID: 12684537 [PubMed - indexed for MEDLINE]Related articlesFree article

Nontuberculous mycobacteria in the HIV infected patient.

Jones D, Havlir DV.

Clin Chest Med. 2002 Sep;23(3):665-74. Review.PMID: 12371002 [PubMed - indexed for MEDLINE]Related articles

Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy.

Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD.

J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):20-6.PMID: 12352146 [PubMed - indexed for MEDLINE]Related articles

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL.

Nat Med. 2002 Apr;8(4):379-85.PMID: 11927944 [PubMed - indexed for MEDLINE]Related articles

Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression.

Appay V, Hansasuta P, Sutton J, Schrier RD, Wong JK, Furtado M, Havlir DV, Wolinsky SM, McMichael AJ, Richman DD, Rowland-Jones SL, Spina CA.

AIDS. 2002 Jan 25;16(2):161-70.PMID: 11807299 [PubMed - indexed for MEDLINE]Related articles

Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?

Havlir DV.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):4-6. No abstract available. PMID: 11782542 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression.

Havlir DV, Gilbert PB, Bennett K, Collier AC, Hirsch MS, Tebas P, Adams EM, Wheat LJ, Goodwin D, Schnittman S, Holohan MK, Richman DD; ACTG 5025 Study Group.

AIDS. 2001 Jul 27;15(11):1379-88.PMID: 11504959 [PubMed - indexed for MEDLINE]Related articles

Prevalence and predictive value of intermittent viremia with combination hiv therapy.

Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Günthard HF, Richman DD, Wong JK.

JAMA. 2001 Jul 11;286(2):171-9.PMID: 11448280 [PubMed - indexed for MEDLINE]Related articlesFree article

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.

Günthard HF, Havlir DV, Fiscus S, Zhang ZQ, Eron J, Mellors J, Gulick R, Frost SD, Brown AJ, Schleif W, Valentine F, Jonas L, Meibohm A, Ignacio CC, Isaacs R, Gamagami R, Emini E, Haase A, Richman DD, Wong JK.

J Infect Dis. 2001 May 1;183(9):1318-27. Epub 2001 Apr 10.PMID: 11294662 [PubMed - indexed for MEDLINE]Related articles

Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients.

Zhou XJ, Havlir DV, Richman DD, Acosta EP, Hirsch M, Collier AC, Tebas P, Sommadossi JP; AIDS Clinical Trials Study 343 Investigators.

AIDS. 2000 Dec 22;14(18):2869-76.PMID: 11153668 [PubMed - indexed for MEDLINE]Related articles

Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.

Havlir DV, Torriani FJ, Schrier RD, Huang JY, Lederman MM, Chervenak KA, Boom WH.

J Clin Microbiol. 2001 Jan;39(1):298-303.PMID: 11136787 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects.

Havlir DV, Schrier RD, Torriani FJ, Chervenak K, Hwang JY, Boom WH.

J Infect Dis. 2000 Dec;182(6):1658-63. Epub 2000 Oct 18.PMID: 11069237 [PubMed - indexed for MEDLINE]Related articles

Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication.

Ioannidis JP, Havlir DV, Tebas P, Hirsch MS, Collier AC, Richman DD.

AIDS. 2000 Jul 28;14(11):1481-8.PMID: 10983634 [PubMed - indexed for MEDLINE]Related articles

In vivo antagonism with zidovudine plus stavudine combination therapy.

Havlir DV, Tierney C, Friedland GH, Pollard RB, Smeaton L, Sommadossi JP, Fox L, Kessler H, Fife KH, Richman DD.

J Infect Dis. 2000 Jul;182(1):321-5. Epub 2000 Jul 6.PMID: 10882616 [PubMed - indexed for MEDLINE]Related articles

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.

Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL.

J Exp Med. 2000 Jul 3;192(1):63-75.PMID: 10880527 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.

O'Brien TR, McDermott DH, Ioannidis JP, Carrington M, Murphy PM, Havlir DV, Richman DD.

AIDS. 2000 May 5;14(7):821-6.PMID: 10839590 [PubMed - indexed for MEDLINE]Related articles

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.

Havlir DV, Hellmann NS, Petropoulos CJ, Whitcomb JM, Collier AC, Hirsch MS, Tebas P, Sommadossi JP, Richman DD.

JAMA. 2000 Jan 12;283(2):229-34.PMID: 10634339 [PubMed - indexed for MEDLINE]Related articlesFree article